Increased use of psychiatric drugs in Brazil over the years: evidence from a country-wide dataset
The trend reported here indicates an association between increased psychiatric drug sales and recent socioeconomic and health crises, including the COVID-19 pandemic, but causality cannot be established. This is possibly just the beginning of a major nationwide challenge that deserves attention going forward so that effective measures are implemented.
Authors
- M Ikeda
- Daniel Pens Gelain (ORCID: https://orcid.org/0000-0001-5254-0509)
- Alana Castro Panzenhagen (ORCID: https://orcid.org/0000-0002-8844-3468)
- Kenju Shimomura (ORCID: https://orcid.org/0000-0002-1539-2532)
- Flávio Shansis (ORCID: https://orcid.org/0000-0003-0423-6291)
- Augusto Cezar Sartori Maffini
- José Cláudio Fonseca Moreira
- Raul Prates Dantas
Institutions
- Univates (BR)
- Universidade Federal do Rio Grande do Sul (BR)
- Universidade do Vale do Rio dos Sinos (BR)
Publication Details
- Journal
- Trends in Psychiatry and Psychotherapy
- Published
- 2025-01-01
- DOI
- https://doi.org/10.47626/2237-6089-2024-0914
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Deutscher Akademischer Austauschdienst
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul
- Universidade Federal do Rio Grande do Sul
- Ministério da Saúde